Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI

NCT00990327 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

863

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Apadenoson SPECT-MPI
DRUG: Adenosine SPECT-MPI

Sponsor

Forest Laboratories

Collaborators

[object Object]